- Title
- Protection of Messenger RNA Vaccines Against Hospitalized Coronavirus Disease 2019 in Adults Over the First Year Following Authorization in the United States
- Creators
- Mark W. Tenforde - CDC FoundationWesley H. Self - Vanderbilt University Medical CenterYuwei Zhu - Vanderbilt University Medical CenterEric A. Naioti - CDC FoundationManjusha Gaglani - Baylor Scott & White HealthAdit A. Ginde - University of Colorado DenverKelly Jensen - University of Colorado DenverH. Keipp Talbot - Vanderbilt University Medical CenterJonathan D. Casey - Vanderbilt University Medical CenterNicholas M. Mohr - University of IowaAnne Zepeski - University of IowaTresa McNeal - Baylor Scott & White HealthShekhar Ghamande - Baylor Scott & White HealthKevin W. Gibbs - Atrium Health Wake Forest BaptistD. Clark Files - Atrium Health Wake Forest BaptistDavid N. Hager - Johns Hopkins HospitalArber Shehu - Johns Hopkins HospitalMatthew E. Prekker - Hennepin County Medical CenterHeidi L. Erickson - Hennepin County Medical CenterMichelle N. Gong - Albert Einstein College of MedicineAmira Mohamed - Albert Einstein College of MedicineNicholas J. Johnson - University of WashingtonVasisht Srinivasan - University of WashingtonJay S. Steingrub - Baystate Medical CenterIthan D. Peltan - Intermountain Medical CenterSamuel M. Brown - Intermountain Medical CenterEmily T. Martin - University of MichiganArnold S. Monto - University of MichiganAkram Khan - Oregon Health and Science University HospitalCatherine L. Hough - Oregon Health and Science University HospitalLaurence W. Busse - Emory UniversityCaitlin Ten Lohuis - Emory UniversityAbhijit Duggal - Cleveland ClinicJennifer G. Wilson - Palo Alto UniversityNida Qadir - Ronald Reagan UCLA Medical CenterSteven Y. Chang - Ronald Reagan UCLA Medical CenterChristopher Mallow - University of MiamiCarolina Rivas - University of MiamiHilary M. Babcock - Washington University in St. LouisJennie H. Kwon - Washington University in St. LouisMatthew C. Exline - The Ohio State University Wexner Medical CenterMena M. Botros - The Ohio State University Wexner Medical CenterAdam S. Lauring - University of MichiganNathan I. Shapiro - Beth Israel Deaconess Medical CenterNatasha Halasa - Vanderbilt University Medical CenterJames D. Chappell - Vanderbilt University Medical CenterCarlos G. Grijalva - Vanderbilt University Medical CenterTodd W. Rice - Vanderbilt University Medical CenterIan D. Jones - Vanderbilt University Medical CenterWilliam B. Stubblefield - Vanderbilt University Medical CenterAdrienne Baughman - Vanderbilt University Medical CenterKelsey N. Womack - Vanderbilt University Medical CenterJillian P. Rhoads - Vanderbilt University Medical CenterChristopher J. Lindsell - Vanderbilt University Medical CenterKimberly W. Hart - Vanderbilt University Medical CenterCaitlin Turbyfill - CDC FoundationSamantha Olson - CDC FoundationNancy Murray - CDC FoundationKatherine Adams - CDC FoundationManish M. Patel - CDC Foundationfor the Influenza and Other Viruses in the Acutely Ill (IVY) Network
- Publication Details
- Clinical infectious diseases, Vol.76(3), pp.E460-E468
- Grant note
- National Heart, Lung, and Blood Institute
- Academic Unit
- Miller School of Medicine; UMMG Dept of Medicine - Pulmonary, Critical Care & Sleep Medicine
- Language
- English
- Resource Type
- Journal article
- PMID
- 35580849
- Record Identifier
- 991032795921702976
Journal article
Protection of Messenger RNA Vaccines Against Hospitalized Coronavirus Disease 2019 in Adults Over the First Year Following Authorization in the United States
Clinical infectious diseases, Vol.76(3), pp.E460-E468
2023-02-08
PMID: 35580849
Metrics
1 Record Views